DK0996447T3 - Kombinationsbehandling til modulation af det humane seksuelle respons - Google Patents

Kombinationsbehandling til modulation af det humane seksuelle respons

Info

Publication number
DK0996447T3
DK0996447T3 DK98922429T DK98922429T DK0996447T3 DK 0996447 T3 DK0996447 T3 DK 0996447T3 DK 98922429 T DK98922429 T DK 98922429T DK 98922429 T DK98922429 T DK 98922429T DK 0996447 T3 DK0996447 T3 DK 0996447T3
Authority
DK
Denmark
Prior art keywords
modulate
combination therapy
sexual response
human sexual
human
Prior art date
Application number
DK98922429T
Other languages
Danish (da)
English (en)
Inventor
Joseph S Podolski
Original Assignee
Zonagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zonagen Inc filed Critical Zonagen Inc
Application granted granted Critical
Publication of DK0996447T3 publication Critical patent/DK0996447T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK98922429T 1997-05-19 1998-05-19 Kombinationsbehandling til modulation af det humane seksuelle respons DK0996447T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4994797P 1997-05-19 1997-05-19

Publications (1)

Publication Number Publication Date
DK0996447T3 true DK0996447T3 (da) 2006-11-13

Family

ID=21962609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98922429T DK0996447T3 (da) 1997-05-19 1998-05-19 Kombinationsbehandling til modulation af det humane seksuelle respons

Country Status (17)

Country Link
EP (1) EP0996447B1 (fr)
JP (2) JP4588809B2 (fr)
KR (1) KR20010012721A (fr)
CN (1) CN1262622A (fr)
AT (1) ATE333279T1 (fr)
AU (1) AU749703B2 (fr)
BR (1) BR9809848A (fr)
CA (1) CA2291160C (fr)
DE (1) DE69835288T2 (fr)
DK (1) DK0996447T3 (fr)
ES (1) ES2270517T3 (fr)
HK (1) HK1028197A1 (fr)
IL (2) IL132853A0 (fr)
NO (1) NO322079B1 (fr)
NZ (1) NZ500921A (fr)
PT (1) PT996447E (fr)
WO (1) WO1998052569A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
US6011043A (en) * 1998-06-19 2000-01-04 Schering Corporation Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
DE19834507A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
US6482426B1 (en) * 1998-09-17 2002-11-19 Zonagen, Inc. Compositions for the treatment of male erectile dysfunction
CA2251255A1 (fr) * 1998-10-20 2000-04-20 Mcgill University L'utilisation d'agents dopaminergique dans le gestion de dysfonctionnement sexuel
US6087362A (en) * 1999-03-16 2000-07-11 Pentech Pharmaceuticals, Inc. Apomorphine and sildenafil composition
JP2002541100A (ja) * 1999-04-06 2002-12-03 ゾナジェン， インコーポレイテッド ヒトの性的応答を調節するための方法
AU5957600A (en) * 1999-07-30 2001-02-19 Lakefield Minerals Ltd. Pharmaceutical compositions for topical application to treat erectile dysfunction
KR100344198B1 (ko) * 1999-10-08 2002-07-19 일양약품주식회사 실데나필 시트레이트의 속효제형
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
KR20020020536A (ko) * 2000-09-09 2002-03-15 장우영 발기유발제
US20100104624A1 (en) * 2008-06-11 2010-04-29 Peter Langecker Combination therapy using phosphodiesterase inhibitors
US7678078B1 (en) 2008-10-21 2010-03-16 KMG Pharma LLC Intravitreal injection device, system and method
GB201221032D0 (en) * 2012-11-22 2013-01-09 Mens Health Ltd Method of treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742054A (en) * 1982-11-23 1988-05-03 Naftchi Nosrat E Treatment of mammals suffering from damage to the central nervous system
ZA878182B (en) * 1986-11-05 1988-05-02 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
FR2649613B1 (fr) * 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
FR2680106B1 (fr) * 1991-08-09 1994-03-11 Corbiere Gerome Procede de realisation de formes pharmaceutiques stables d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
ES2256999T3 (es) * 1994-04-22 2006-07-16 Pentech Pharmaceuticals, Inc. Composcion sublingual que contiene apomorfina para el diagnostico de la impotencia funcional.
CN1113757A (zh) * 1994-06-24 1995-12-27 王儒新 一种性功能促进剂及其制备方法
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
JPH09110674A (ja) * 1995-10-16 1997-04-28 Kao Corp 浴用剤組成物

Also Published As

Publication number Publication date
CA2291160C (fr) 2008-10-28
WO1998052569A1 (fr) 1998-11-26
CN1262622A (zh) 2000-08-09
ES2270517T3 (es) 2007-04-01
EP0996447B1 (fr) 2006-07-19
PT996447E (pt) 2006-12-29
HK1028197A1 (en) 2001-02-09
JP2001526686A (ja) 2001-12-18
NO995657D0 (no) 1999-11-18
NZ500921A (en) 2002-11-26
CA2291160A1 (fr) 1998-11-26
KR20010012721A (ko) 2001-02-26
ATE333279T1 (de) 2006-08-15
DE69835288T2 (de) 2007-07-19
IL132853A (en) 2010-04-15
AU7498098A (en) 1998-12-11
EP0996447A1 (fr) 2000-05-03
IL132853A0 (en) 2001-03-19
NO995657L (no) 2000-01-18
NO322079B1 (no) 2006-08-14
BR9809848A (pt) 2000-06-27
DE69835288D1 (de) 2006-08-31
JP2009280621A (ja) 2009-12-03
AU749703B2 (en) 2002-07-04
JP4588809B2 (ja) 2010-12-01

Similar Documents

Publication Publication Date Title
DK0996447T3 (da) Kombinationsbehandling til modulation af det humane seksuelle respons
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
ES2168650T3 (es) Compuestos y metodos moduladores de receptores de androgenos.
DK0873295T3 (da) Dimer-selektive RXR-modulatorer og fremgangsmåder til deres anvendelse
EA200200208A1 (ru) Синергитическая композиция
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
DK0714300T3 (da) Fremgangsmåder til regulering af den seksuelle reaktion hos mennesker
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
BR9510486A (pt) Compostos moduladores de receptores de esteróide e métodos
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
CY1105125T1 (el) Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
DZ3265A1 (fr) Derives de 4,5-diaryl-3(2h)-furanone comme inhibiteurs de cyclo-oxygenase-2
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
PT1032414E (pt) Combinacao de um inibidor da enzima de conversao da angiotensina e de um diuretico para o tratamento de perturbacoes microcirculatorias
DE69614149T2 (de) Chinolinderivate als antimalariamittel
DE69814894D1 (de) Isochinolin derivate als urokinase inhibitoren
ES2180573T3 (es) Uso de derivados de indol como antagonistas de 5ht1.
NO20001548L (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat
ATE337320T1 (de) Indolderivate als pde5-inhibitoren
NO20005548D0 (no) Mykobakterieinhibitorer
ES2179377T3 (es) N-(piridinilamino)isoindolinas y compuestos relacionados.